Economic evaluations in pain management: Principles and methods

Journal of Pain and Palliative Care Pharmacotherapy

Volumn 20, Issue 3, 2006, Pages 15-23

  Asche, Carl V ^a,d   Seal, Brian ^b   Jackson II, Kenneth C ^c   Oderda, Gary M ^c  

^a UNIVERSITY OF UTAH   (United States)

^b UNIVERSITY OF THE SCIENCES   (United States)

^c PORC ^*

^d Pharmacotherapy Outcomes Research Center   (United States)

Author keywords

Cost benefit; Design; Economics; Health services; Methods; Pain; Randomized controlled trials; Research; Sensitivity; Specificity; Statistics

Indexed keywords

ANALGESIC AGENT;

AB INITIO CALCULATION; ARTICLE; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; COST MINIMIZATION ANALYSIS; COST UTILITY ANALYSIS; ECONOMIC EVALUATION; HEALTH CARE COST; HEALTH SERVICE; PAIN; PSYCHOLOGICAL WELL BEING; QUALITY OF LIFE;

COSTS AND COST ANALYSIS; ECONOMICS, PHARMACEUTICAL; PAIN; QUALITY OF LIFE; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN;

EID: 33747878565     PISSN: 15360288     EISSN: 15360539     Source Type: Journal    
DOI: 10.1300/J354v20n03_04     Document Type: Article

References (5)

1. Oderda GM. The importance of perspective in pharmacoeconomic analyses. J Pain Palliat Care Pharmacother. 2002;16(4):65-9.
2. Rogers W, Wittink H, Wagner A, et al. Assessing individual outcomes during outpatient multidisciplinary chronic pain treatment by means of an augmented SF-36. Pain Med. 2000;1(1):44-54.
3. Rogers WH, Wittink HM, Ashburn MA, et al. Using the TOPS, an outcomes instrument for interdisciplinary outpatient pain treatment. Pain Med. 2000;1(1):55-67.
4. Ho M-J, LaFleur J. The Treatment Outcomes of Pain Survey (TOPS): A clinical monitoring and outcomes instrument for chronic pain practice and research. J Pain Palliative Care Pharmacother. 2004;18(2):9-59.
5. hjttp://www.who.int/about/definition/en/ accessed February 15, 2006.